Longitudinal inter- and intra-individual human brain metabolic quantification over 3 years with proton MR spectroscopy at 3 T

Magnetic Resonance in Medicine

Volumn 67, Issue 1, 2012, Pages 27-33

  Kirov, Ivan I ^a   George, Ilena C ^a   Jayawickrama, Nikhil ^a   Babb, James S ^a   Perry, Nissa N ^a   Gonen, Oded ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain; diffuse pathology; MR spectroscopy; repeatability

Indexed keywords

BRAIN; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; PATHOLOGY;

COEFFICIENTS OF VARIATIONS; HEALTHY HUMANS; MR SPECTROSCOPY; MYO-INOSITOL; N-ACETYLASPARTATE; NARROW-LINE WIDTH; PROTON MR SPECTROSCOPY; REPEATABILITY;

SIGNAL TO NOISE RATIO;

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ACCURACY; ADULT; ARTICLE; BRAIN; FEMALE; HUMAN; MALE; METABOLITE; NORMAL HUMAN; PATHOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; SPECTRUM;

EID: 84355163075     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.23001     Document Type: Article

References (24)

1. Mountford CE, Stanwell P, Lin A, Ramadan S, Ross B,. Neurospectroscopy: the past, present and future. Chem Rev 2010; 110: 3060-3086.
2. Traber F, Block W, Freymann N, Gur O, Kucinski T, Hammen T, Ende G, Pilatus U, Hampel H, Schild HH, Heun R, Jessen F,. A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe. Eur Radiol 2006; 16: 1096-1103.
3. Maudsley AA, Domenig C, Sheriff S,. Reproducibility of serial whole-brain MR spectroscopic imaging. NMR Biomed 2010; 23: 251-256.
4. Gasparovic C, Bedrick EJ, Mayer AR, Yeo RA, Chen H, Damaraju E, Calhoun VD, Jung RE,. Test-retest reliability and reproducibility of short-echo-time spectroscopic imaging of human brain at 3T. Magn Reson Med 2011 [Epub ahead of print].
5. Hancu I, Blezek DJ, Dumoulin MC,. Automatic repositioning of single voxels in longitudinal 1H MRS studies. NMR Biomed 2005; 18: 352-361. (Pubitemid 41410355)
6. Wellard RM, Briellmann RS, Jennings C, Jackson GD,. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T. AJNR Am J Neuroradiol 2005; 26: 585-590. (Pubitemid 43085962)
7. Wijnen JP, van Asten JJ, Klomp DW, Sjobakk TE, Gribbestad IS, Scheenen TW, Heerschap A,. Short echo time 1H MRSI of the human brain at 3T with adiabatic slice-selective refocusing pulses; reproducibility and variance in a dual center setting. J Magn Reson Imaging 2010; 31: 61-70.
8. Kreis R, Slotboom J, Hofmann L, Boesch C,. Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects. Magn Reson Med 2005; 54: 761-768. (Pubitemid 41457045)
9. Goelman G, Liu S, Hess D, Gonen O,. Optimizing the efficiency of high-field multivoxel spectroscopic imaging by multiplexing in space and time. Magn Reson Med 2006; 56: 34-40.
10. Ashburner J, Friston KJ,. Voxel-based morphometry-the methods. Neuroimage 2000; 11 (6 Pt 1): 805-821.
11. Soher BJ, Young K, Govindaraju V, Maudsley AA,. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998; 40: 822-831. (Pubitemid 28543833)
12. Inglese M, Li BS, Rusinek H, Babb JS, Grossman RI, Gonen O,. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med 2003; 50: 190-195. (Pubitemid 36841875)
13. Kirov I, Fleysher L, Fleysher R, Patil V, Liu S, Gonen O,. Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med 2008; 60: 790-795.
14. Posse S, Otazo R, Caprihan A, Bustillo J, Chen H, Henry PG, Marjanska M, Gasparovic C, Zuo C, Magnotta V, Mueller B, Mullins P, Renshaw P, Ugurbil K, Lim KO, Alger JR,. Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla. Magn Reson Med 2007; 58: 236-244. (Pubitemid 47267640)
15. Traber F, Block W, Lamerichs R, Gieseke J, Schild HH,. 1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004; 19: 537-545. (Pubitemid 38619915)
16. Brooks WM, Friedman SD, Stidley CA,. Reproducibility of 1H-MRS in vivo. Magn Reson Med 1999; 41: 193-197.
17. Li BS, Regal J, Gonen O,. SNR versus resolution in 3D 1H MRS of the human brain at high magnetic fields. Magn Reson Med 2001; 46: 1049-1053. (Pubitemid 33104290)
18. De Stefano N, Filippi M, Miller D, Pouwels PJ, Rovira A, Gass A, Enzinger C, Matthews PM, Arnold DL,. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology 2007; 69: 1942-1952. (Pubitemid 350100353)
19. Miller DH,. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 2004; 1: 284-294. (Pubitemid 46591886)
20. Kirov I, Patil V, Babb JS, Rusinek H, Herbert J, Gonen O,. MR spectroscopy indicates diffuse multiple sclerosis activity during remission. J Neurol Neurosurg Psychiatry 2009; 80: 1330-1336.
21. Barker P,. Fundamentals of MR spectroscopy. In: Clinical MR Neuroimaging., Barker P, editor. Cambridge: Cambridge University Press; 2005. pp 7-27.
22. Rosen Y, Lenkinski RE,. Recent advances in magnetic resonance neurospectroscopy. Neurotherapeutics 2007; 4: 330-345. (Pubitemid 46962408)
23. Chard DT, McLean MA, Parker GJ, MacManus DG, Miller DH,. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 2002; 15: 219-225. (Pubitemid 34112915)
24. Li BS, Babb JS, Soher BJ, Maudsley AA, Gonen O,. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002; 47: 439-446. (Pubitemid 34193997)